The global Chemotherapy-Induced Nausea and Vomiting Drugs market was valued at US$ 2501 million in 2022 and is projected to reach US$ 3351.1 million by 2029, at a CAGR of 4.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Chemotherapy-Induced Nausea and Vomiting Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy-Induced Nausea and Vomiting Drugs. This report contains market size and forecasts of Chemotherapy-Induced Nausea and Vomiting Drugs in global, including the following market information:
- Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Sales, 2018-2023, 2024-2032, (K Units)
- Global top five Chemotherapy-Induced Nausea and Vomiting Drugs companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Existing Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs include Merck & Co., Inc., GlaxoSmithKline plc, Tesaro, Inc., Helsinn Group, F. Hoffmann-La Roche Ltd., Heron Therapeutics, Inc., Dr. Reddy's Laboratories Ltd., Acacia Pharma and Sun Pharmaceutical Industry Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chemotherapy-Induced Nausea and Vomiting Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, by Type, 2022 (%)
- Existing Drugs
- Akynzeo (Netupitant-Palonosetron FDC)
- Aloxi (Palonosetron)
- Emend (Aprepitant)
- Kytril Generic (Granisetron)
- Zofran Generic (Ondansetron)
- Pipeline Drugs
- SUSTOL (Granisetron Injection extended release)
- Rolapitant
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, by Application, 2022 (%)
- Serotonin Receptor Antagonists
- NK1 Receptor Antagonists
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs revenues share in global market, 2022 (%)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Chemotherapy-Induced Nausea and Vomiting Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Tesaro, Inc.
- Helsinn Group
- F. Hoffmann-La Roche Ltd.
- Heron Therapeutics, Inc.
- Dr. Reddy's Laboratories Ltd.
- Acacia Pharma
- Sun Pharmaceutical Industry Ltd.
- Otsuka Holdings Co., Ltd.
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Chemotherapy-Induced Nausea and Vomiting Drugs, market overview.
- Chapter 2: Global Chemotherapy-Induced Nausea and Vomiting Drugs market size in revenue and volume.
- Chapter 3: Detailed analysis of Chemotherapy-Induced Nausea and Vomiting Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Chemotherapy-Induced Nausea and Vomiting Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Chemotherapy-Induced Nausea and Vomiting Drugs capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Overall Market Size
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2022 VS 2032
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, Prospects & Forecasts: 2018-2032
2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales: 2018-2032
3 Company Landscape
3.1 Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.2 Top Global Chemotherapy-Induced Nausea and Vomiting Drugs Companies Ranked by Revenue
3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies
3.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies
3.5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Chemotherapy-Induced Nausea and Vomiting Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size Markets, 2022 & 2032
4.1.2 Existing Drugs
4.1.3 Akynzeo (Netupitant-Palonosetron FDC)
4.1.4 Aloxi (Palonosetron)
4.1.5 Emend (Aprepitant)
4.1.6 Kytril Generic (Granisetron)
4.1.7 Zofran Generic (Ondansetron)
4.1.8 Pipeline Drugs
4.1.9 SUSTOL (Granisetron Injection extended release)
4.1.10 Rolapitant
4.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
4.2.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2023
4.2.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2024-2032
4.2.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
4.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
4.3.1 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2023
4.3.2 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2024-2032
4.3.3 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
4.4 By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2022 & 2032
5.1.2 Serotonin Receptor Antagonists
5.1.3 NK1 Receptor Antagonists
5.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
5.2.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2023
5.2.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2024-2032
5.2.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
5.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
5.3.1 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2023
5.3.2 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2024-2032
5.3.3 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
5.4 By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (Manufacturers Selling Prices), 2018-2032
6 Sights by Region
6.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2022 & 2032
6.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue & Forecasts
6.2.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2023
6.2.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2024-2032
6.2.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
6.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales & Forecasts
6.3.1 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2023
6.3.2 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2024-2032
6.3.3 By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
6.4 North America
6.4.1 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.4.2 By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.4.3 US Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.4.4 Canada Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.4.5 Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5 Europe
6.5.1 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.5.2 By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.5.3 Germany Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.4 France Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.5 U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.6 Italy Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.7 Russia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.8 Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.5.9 Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6 Asia
6.6.1 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.6.2 By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.6.3 China Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6.4 Japan Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6.5 South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.6.7 India Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.7 South America
6.7.1 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.7.2 By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.7.3 Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.7.4 Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032
6.8.2 By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, 2018-2032
6.8.3 Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.8.4 Israel Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.8.5 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
6.8.6 UAE Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, 2018-2032
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Company Summary
7.1.2 Merck & Co., Inc. Business Overview
7.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Merck & Co., Inc. Key News & Latest Developments
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Company Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline plc Key News & Latest Developments
7.3 Tesaro, Inc.
7.3.1 Tesaro, Inc. Company Summary
7.3.2 Tesaro, Inc. Business Overview
7.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Tesaro, Inc. Key News & Latest Developments
7.4 Helsinn Group
7.4.1 Helsinn Group Company Summary
7.4.2 Helsinn Group Business Overview
7.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Helsinn Group Key News & Latest Developments
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Company Summary
7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.6 Heron Therapeutics, Inc.
7.6.1 Heron Therapeutics, Inc. Company Summary
7.6.2 Heron Therapeutics, Inc. Business Overview
7.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Heron Therapeutics, Inc. Key News & Latest Developments
7.7 Dr. Reddy's Laboratories Ltd.
7.7.1 Dr. Reddy's Laboratories Ltd. Company Summary
7.7.2 Dr. Reddy's Laboratories Ltd. Business Overview
7.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Dr. Reddy's Laboratories Ltd. Key News & Latest Developments
7.8 Acacia Pharma
7.8.1 Acacia Pharma Company Summary
7.8.2 Acacia Pharma Business Overview
7.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Acacia Pharma Key News & Latest Developments
7.9 Sun Pharmaceutical Industry Ltd.
7.9.1 Sun Pharmaceutical Industry Ltd. Company Summary
7.9.2 Sun Pharmaceutical Industry Ltd. Business Overview
7.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Sun Pharmaceutical Industry Ltd. Key News & Latest Developments
7.10 Otsuka Holdings Co., Ltd.
7.10.1 Otsuka Holdings Co., Ltd. Company Summary
7.10.2 Otsuka Holdings Co., Ltd. Business Overview
7.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Major Product Offerings
7.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Otsuka Holdings Co., Ltd. Key News & Latest Developments
8 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Analysis
8.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, 2018-2032
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chemotherapy-Induced Nausea and Vomiting Drugs Supply Chain Analysis
10.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Upstream Market
10.3 Chemotherapy-Induced Nausea and Vomiting Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Chemotherapy-Induced Nausea and Vomiting Drugs in Global Market
Table 2. Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
Table 9. List of Global Tier 1 Chemotherapy-Induced Nausea and Vomiting Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chemotherapy-Induced Nausea and Vomiting Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2024-2032
Table 14. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2024-2032
Table 16. By Application ? Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2022 & 2032
Table 17. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2024-2032
Table 19. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2024-2032
Table 21. By Region ? Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2022 VS 2032
Table 22. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (US$, Mn), 2024-2032
Table 24. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), 2024-2032
Table 26. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2024-2032
Table 30. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2024-2032
Table 32. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2024-2032
Table 34. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2024-2032
Table 36. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2024-2032
Table 38. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2024-2032
Table 40. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2024-2032
Table 42. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2024-2032
Table 44. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales, (K Units), 2024-2032
Table 46. Merck & Co., Inc. Company Summary
Table 47. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 48. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck & Co., Inc. Key News & Latest Developments
Table 50. GlaxoSmithKline plc Company Summary
Table 51. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 52. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. GlaxoSmithKline plc Key News & Latest Developments
Table 54. Tesaro, Inc. Company Summary
Table 55. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 56. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Tesaro, Inc. Key News & Latest Developments
Table 58. Helsinn Group Company Summary
Table 59. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 60. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Helsinn Group Key News & Latest Developments
Table 62. F. Hoffmann-La Roche Ltd. Company Summary
Table 63. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 64. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 66. Heron Therapeutics, Inc. Company Summary
Table 67. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 68. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Heron Therapeutics, Inc. Key News & Latest Developments
Table 70. Dr. Reddy's Laboratories Ltd. Company Summary
Table 71. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 72. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Dr. Reddy's Laboratories Ltd. Key News & Latest Developments
Table 74. Acacia Pharma Company Summary
Table 75. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 76. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Acacia Pharma Key News & Latest Developments
Table 78. Sun Pharmaceutical Industry Ltd. Company Summary
Table 79. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 80. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Sun Pharmaceutical Industry Ltd. Key News & Latest Developments
Table 82. Otsuka Holdings Co., Ltd. Company Summary
Table 83. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Offerings
Table 84. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Otsuka Holdings Co., Ltd. Key News & Latest Developments
Table 86. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Chemotherapy-Induced Nausea and Vomiting Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production by Region, 2024-2032 (K Units)
Table 90. Chemotherapy-Induced Nausea and Vomiting Drugs Market Opportunities & Trends in Global Market
Table 91. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers in Global Market
Table 92. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints in Global Market
Table 93. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Materials
Table 94. Chemotherapy-Induced Nausea and Vomiting Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Chemotherapy-Induced Nausea and Vomiting Drugs Downstream
Table 96. Chemotherapy-Induced Nausea and Vomiting Drugs Downstream Clients in Global Market
Table 97. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Type in 2022
Figure 2. Chemotherapy-Induced Nausea and Vomiting Drugs Segment by Application in 2022
Figure 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Global Market: 2018-2032 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting Drugs Revenue in 2022
Figure 9. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 10. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
Figure 11. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
Figure 12. By Type - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit), 2018-2032
Figure 13. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 14. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
Figure 15. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
Figure 16. By Application - Global Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit), 2018-2032
Figure 17. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 18. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018 VS 2022 VS 2032
Figure 19. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
Figure 20. By Region - Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
Figure 21. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
Figure 22. By Country - North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
Figure 23. US Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
Figure 27. By Country - Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
Figure 28. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. France Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. Nordic Countries Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Benelux Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
Figure 36. By Region - Asia Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
Figure 37. China Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. India Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 42. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
Figure 43. By Country - South America Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
Figure 44. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 45. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 46. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share, 2018-2032
Figure 47. By Country - Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share, 2018-2032
Figure 48. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 49. Israel Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 50. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 51. UAE Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$, Mn), 2018-2032
Figure 52. Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity (K Units), 2018-2032
Figure 53. The Percentage of Production Chemotherapy-Induced Nausea and Vomiting Drugs by Region, 2022 VS 2032
Figure 54. Chemotherapy-Induced Nausea and Vomiting Drugs Industry Value Chain
Figure 55. Marketing Channels
